Searched for
LENALIDOMIDE CAPSULES
Sun Pharma gets USFDA nod to market generic medicationIn June 2021, Sun Pharma entered into a settlement with Celgene Corporation (Celgene) to resolve the patent litigation regarding its generi...10 Feb, 2023, 01.15 PM IST- Dr Reddy’s Q2 Results: Profit jumps 12% YoY to Rs 1,114 crore; revenue rises 9.4%Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) for the quarter rose about 40% on year to Rs 1,899 cro...28 Oct, 2022, 05.09 PM IST
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...08 Sep, 2022, 01.04 PM IST
- Buy Natco Pharma, target price Rs 1021: ICICI SecuritiesNatco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 15529.31 Crore) operating in Pharmaceutic...09 Mar, 2022, 10.28 AM IST
- Natco Pharma announces launch of first generic of top selling cancer drug RevlimidRevlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...07 Mar, 2022, 10.35 PM IST
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...19 Oct, 2021, 12.22 PM IST
- Dr Reddy's launches cancer drug in Canada"Our launch of Reddy-Lenalidomide represents our firm commitment to providing access to affordable medicines for Canada's Multiple Myeloma ...02 Sep, 2021, 09.59 AM IST
- Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...22 Jun, 2021, 11.18 AM IST
- Sun Pharma inches up as the company settles a patent litigationPursuant to the terms of the settlement, Celgene will grant Sun Pharma a licensc to Celgene’s patents required to manufacture and sell (sub...22 Jun, 2021, 10.27 AM IST
- Natco Pharma shares hit upper circuit. Here's whyThe Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.24 May, 2021, 11.36 AM IST
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...22 May, 2021, 03.05 PM IST
- Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drugNatco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types ...10 Jul, 2020, 12.48 PM IST
- Dr Reddy's settles case with Celgene on cancer drugREVLIMID (Lenalidomide) is indicated for treatment for multiple myeloma (cancer).02 Apr, 2019, 03.45 PM IST
- Natco Pharma launches generic blood cancer drug in IndiaNatco has launched pomalidomide capsules in strengths of 1 mg, 2 mg and 4 mg in India.10 May, 2017, 11.07 AM IST
- Natco settles patent litigation with Celgene on cancer drugNatco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment...23 Dec, 2015, 02.23 PM IST
- Natco Pharma open to settle cancer drug patent case with US coNatco Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp, which has said it would file a complaint ...10 Sep, 2010, 06.22 PM IST
- Natco Pharma introduces Lenalidomide genericNatco Pharma has introduced the generic version of Lenalidomide, which is indicated for the treatment of Myelo Dysplastic Syndrome.11 Sep, 2007, 02.40 PM IST
Load More
